Literature DB >> 11908168

[Pemphigoid and acquired hemophilia].

E Lightburn1, J J Morand, B Graffin, S Molinier, G Raphenon, P Poullin, J R Harlé, C Chouc.   

Abstract

INTRODUCTION: The association of bullous pemphigoid and acquired haemophilia is reported. CASE-REPORT: A 74 year-old man developed a bullous pemphigoid after decreasing corticotherapy, ecchymosis and haematomas revealing a high level of acquired anti-VIII antibodies (110 Bethesda UB units; TCA 98 s). Immunosuppressive treatment (cyclosporine, prednisone, azathioprine and bolus of cyclophosphamide) did not stop the disease. Perfusion of recombinant factor VIIa, human immunoglobulins and prednisone-azathioprine association permitted clinical and biological remission. DISCUSSION: Acquired haemophilia is idiopathic half the time. It can appear in autoimmmune diseases. Mortality is high. Only 4 cases of association with bullous pemphigoid have been reported in the literature. At the haemorrhagic phase, porcine factor VIII or more recombinant activated factor VII with human immunoglobulins are necessary. Immunosuppressive treatment is used to decrease production of anti-factor VIII antibodies.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11908168

Source DB:  PubMed          Journal:  Ann Dermatol Venereol        ISSN: 0151-9638            Impact factor:   0.777


  3 in total

1.  Acquired haemophilia heralded by bleeding into the oral mucosa in a patient with bullous pemphigoid, rheumatoid arthritis, and vitiligo.

Authors:  R S Patel; K E Harman; C Nichols; R M Burd; S Pavord
Journal:  Postgrad Med J       Date:  2006-01       Impact factor: 2.401

2.  Successful Management of Acquired Hemophilia A Associated with Bullous Pemphigoid: A Case Report and Review of the Literature.

Authors:  Quentin Binet; Catherine Lambert; Laurine Sacré; Stéphane Eeckhoudt; Cedric Hermans
Journal:  Case Rep Hematol       Date:  2017-03-28

3.  Bullous Pemphigoid Associated with Acquired Hemophilia A: A Case Report and Review of the Literature.

Authors:  Wuttidej Fakprapai; Penpun Wattanakrai
Journal:  Case Rep Dermatol       Date:  2019-05-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.